ELV

Elevance Health Inc

ELV.US elevancehealth.com + Research + Basket
CIK 0001156039
Employees 96,129
Phone 833 401 1577
Fiscal year end December
IPO Jan 02, 2001
Address 220 Virginia Avenue, Indianapolis, IN, United States, 46204
422.02
+7.61 (+1.84%)
USD · NYSE
52-week range
270.87
450.69
Trading at 84% of the 52-week range
Market Cap
91.41B
P/E Ratio
17.90
Forward P/E
14.39
Book Value
206.75
Div. Yield
1.59%
% Institutions
94.38%
% Insiders
0.185%

1 Year

+28.0%

3 Year

-1.0%

10 Year

+297.5%
Description

Elevance Health, Inc., together with its subsidiaries, operates as a health benefits company in the United States. The company operates in four segments: Health Benefits, CarelonRx, Carelon Services, and Corporate & Other. It offers a variety of health plans and services to individual, employer group risk-based and fee-based, BlueCard, Medicare, Medicaid, and FEP members; health products; a broad array of fee-based administrative managed care services; and specialty and other insurance products and services, such as stop loss, dental, vision, and supplemental health insurance benefits. The company also operates in the pharmacy services business; and markets and offers pharmacy services, including home delivery and specialty pharmacies, claims adjudication, formulary management, pharmacy networks, rebate administration, a prescription drug database, and member services, as well as infusion services and injectable therapies through ambulatory infusion centers. In addition, it provides healthcare related services and capabilities, including specialty care enablement and utilization management support for specialized clinical domains; behavioral health and comprehensive care management services; palliative care services and management; virtual care; and payment integrity, subrogation, clinical data exchange through its HealthOS platform, research and data, reporting and clinical analytics, information technology, and business process support services, as well as manages home health, post-acute institutional management, and durable medical equipment costs; and supports plans in managing home and community-based services. The company provides its services under the Anthem Blue Cross and Blue Shield, Wellpoint, and Carelon brands. The company was formerly known as Anthem, Inc. and changed its name to Elevance Health, Inc. in June 2022. Elevance Health, Inc. was incorporated in 2001 and is based in Indianapolis, Indiana.

Actions

Add an action for ELV.US, or sign in to see your action list.

People

▼

Directors & Officers

Name Title Year Born
Ms. Gail Koziara Boudreaux President, CEO & Director 1961
Mr. Mark Bradley Kaye Executive VP & CFO 1980
Mr. Peter David Haytaian Esq. Special Advisor 1970
Mr. Charles Morgan Kendrick Jr. EVP and President of Commercial & Specialty Health Benefits 1966
Ms. Felicia Farr Norwood Executive VP & Chief Health Benefits Officer 1960
Mr. Scott Wayne Anglin SVP, Treasurer & Chief Investment Officer NA
Mr. Ronald William Penczek Senior VP, Controller & Chief Accounting Officer 1965
Mr. Nathan Allen Rich Vice President of Investor Relations NA
Ms. Erin M. Wessling Executive VP & Chief Legal Officer 1978
Ms. Julie Goon Senior Vice President of Public Affairs NA

Insider Trading

Open insider trading
Date Insider Name Title Transaction Type Shares Price Value SEC
Mar 30, 2026 Ro Khanna N/A Sale N/A $284.64 N/A —
Mar 12, 2026 Amy W Schulman N/A Sale 26.00 $287.50 $7.48K SEC
Feb 24, 2026 Ro Khanna N/A Purchase N/A $326.91 N/A —
Feb 17, 2026 Ro Khanna N/A Purchase N/A $344.40 N/A —
Jan 29, 2026 Ro Khanna N/A Sale N/A $346.33 N/A —
Dec 29, 2025 Markwayne Mullin N/A Purchase N/A $348.44 N/A —
Nov 03, 2025 Ro Khanna N/A Sale N/A $313.10 N/A —
Oct 27, 2025 Michael T. McCaul N/A Sale N/A $341.90 N/A —
Sep 29, 2025 Ro Khanna N/A Purchase N/A $319.52 N/A —
Sep 05, 2025 Ro Khanna N/A Purchase N/A $313.79 N/A —
Aug 26, 2025 Ro Khanna N/A Purchase N/A $309.89 N/A —
Aug 21, 2025 Michael T. McCaul N/A Sale N/A $309.45 N/A —
Aug 19, 2025 Susan D Devore N/A Purchase 1.20K $312.15 $374.58K SEC
Aug 13, 2025 Lisa C. McClain N/A Sale N/A $294.18 N/A —
Aug 05, 2025 Gilbert Ray Cisneros, Jr. N/A Purchase N/A $276.45 N/A —
Aug 04, 2025 Ro Khanna N/A Sale N/A $274.84 N/A —
Jul 25, 2025 Ro Khanna N/A Sale N/A $289.11 N/A —
Jul 18, 2025 Gail Boudreaux N/A Purchase 8.50K $286.94 $2.44M SEC

Shareholders

▼

Institutional Holders

Holder Name Shares Date Reported % Out Value % Change
BlackRock Inc 18.99M Jun 30, 2026 8.76% $0.11 -4.51%
Vanguard Capital Management, LLC 14.06M Jun 30, 2026 6.48% $0.12 -2.00%
State Street Corp 10.43M Jun 30, 2026 4.81% $0.12 1.34%
Wellington Management Company LLP 9.21M Jun 30, 2026 4.25% $0.61 11.97%
Arnhold & S. Bleichroeder Advisers, LLC 8.38M Jun 30, 2026 3.86% $2.68 102.71%
Vanguard Portfolio Management, LLC 6.21M Jun 30, 2026 2.87% $0.11 -2.23%
Sanders Capital, LLC 5.83M Jun 30, 2026 2.69% $2.26 -1.18%
Geode Capital Management, LLC 5.17M Jun 30, 2026 2.38% $0.11 -0.51%
Harris Associates L.P. 4.92M Jun 30, 2026 2.27% $2.53 2.67%
Artisan Partners Limited Partnership 4.58M Jun 30, 2026 2.11% $2.81 -10.65%
Amvescap Plc. 4.23M Jun 30, 2026 1.95% $0.13 -12.11%
T. Rowe Price Associates, Inc. 4.01M Jun 30, 2026 1.85% $0.16 -15.41%
NORGES BANK 3.96M Jun 30, 2026 1.83% $0.15 31.15%
Bank of New York Mellon Corp 3.22M Jun 30, 2026 1.49% $0.20 13.27%
FMR Inc 3.13M Jun 30, 2026 1.44% $0.05 58.51%
Morgan Stanley - Brokerage Accounts 2.61M Jun 30, 2026 1.20% $0.05 -0.89%
Northern Trust Corp 2.11M Jun 30, 2026 0.98% $0.10 -1.99%
Citigroup Inc 2.10M Jun 30, 2026 0.97% $0.27 777.90%
UBS Asset Mgmt Americas Inc 2.07M Jun 30, 2026 0.95% $0.15 -17.99%
Hotchkis & Wiley Capital Management LLC 2.02M Jun 30, 2026 0.93% $2.27 -8.00%

Fund Holdings

Rank Holder Name Shares Held % of Shares Change Date Reported
1 Vanguard MStar Total Stk Mkt Idx Invest 6.71M 3.09% ▼ 0.99% Sep 30, 2026
2 Vanguard 500 Index Investor 5.54M 2.56% ▼ 2.05% Sep 30, 2026
3 Vanguard Windsor II Inv 3.05M 1.41% ▼ 0.28% Jun 30, 2026
4 iShares Core S&P 500 ETF 2.89M 1.33% ▼ 0.16% Sep 30, 2026
5 First Eagle Global A 2.84M 1.31% ▲ 0.00% Sep 30, 2026
6 Fidelity 500 Index 2.82M 1.30% ▲ 0.39% Aug 31, 2026
7 State Street® SPDR® S&P 500® ETF 2.66M 1.23% ▲ 0.00% Sep 30, 2026
8 Vanguard Equity-Income Inv 2.05M 0.94% ▼ 1.87% Jun 30, 2026
9 Vanguard MStar Value Index Investor 2.01M 0.93% ▼ 0.56% Sep 30, 2026
10 Vanguard Health Care Inv 1.86M 0.86% ▼ 1.12% Jun 30, 2026

Financial Highlights

▼
Market Cap: $91.41B
EBITDA: $8.71B
P/E Ratio: $17.90
PEG Ratio: $1.32
Book Value: $206.75
Dividend/Share: $6.87
Dividend Yield: 1.59%
Earnings/Share: $23.55
Profit Margin: 2.55%
Operating Margin: 4.22%
ROA (TTM): 4.01%
ROE (TTM): 11.48%
Revenue (TTM): $201.83B
Revenue/Share (TTM): $923.29
Earnings Growth (YOY): 17.90%
Revenue Growth (YOY): 1.40%

Valuation Metrics

Enterprise Value: $111.82B
Trailing P/E: 17.90
Forward P/E: 14.39

Shares Statistics

Shares Outstanding: 216.87M
Shares Float: 215.57M
% Insiders: 0.185%
% Institutions: 94.38%
Short % Float: 2.65%

Stock Price History

▼

1 Year Price History

3 Years Price History

10 Years Price History

Max Price History

Financial Charts

▼
Open balance sheet Open capital intensity Download Financials (Excel)

Revenue, Net Income & Operating Cash Flow (Yearly)

Change % vs Prior Year

Revenue, Net Income & Operating Cash Flow (Quarterly)

Change % vs Prior Quarter

Operating Expenses (Yearly)

Operating Expenses (Quarterly)

Balance Sheet (Yearly)

Balance Sheet (Quarterly)

Assets Breakdown (Yearly)

Assets Breakdown (Quarterly)

Liabilities Breakdown (Yearly)

Liabilities Breakdown (Quarterly)

Income Statement Waterfall

▼
Open full waterfall Open balance sheet
Line Item
Step Type
Value
Revenue
adjust
$199.13B
Cost of Goods Sold
adjust
$-148.22B
Gross Profit
subtotal
$50.90B
Other Operating Expense
adjust
$-42.79B
Operating Income
subtotal
$8.11B
Other / Non-Operating Items
adjust
$-2.45B
Net Income
subtotal
$5.66B

Earnings Per Share (EPS) History

▼

Financial Ratios

▼

📦 Raw API Data (JSON Explorer)

▼

Assistant

×
Hello! I'm your AI assistant. I have access to the financial data on this page. Ask me anything about ELV.US!